Approval of peanut allergy treatment in the US.

in Uncategorized

The Food and Drug Administration in the US has approved immunotherapy as a treatment to mitigate the risk of allergic reactions that may occur, including anaphylaxis, after accidental exposure to peanut in patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy.

To see the press release issued by the American Academy of Allergy, Asthma and Immunology click here

IFAN would love to see this decision replicated by the relevant authorities in Ireland.